Brind.
  1. Major pharmaceutical companies including Sanofi, Regeneron, Roche, Eli Lilly, Biogen, and Gilead are maintaining alliances and competing across key therapeutic areas like ophthalmology, immunology, and oncology.
  2. Sanofi, Regeneron, and Bayer are involved in new market developments, including FDA submissions regarding eczema and eye care treatments.

Regeneron and Sanofi are seeking FDA approval for EYLEA HD pre-filled syringe and discussing collaboration expansion.

1 report, 1 independent Updated Jul 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Regeneron and Sanofi are seeking FDA approval for EYLEA HD pre-filled syringe and discussing collaboration expansion.

Who's involved

What this event is mainly about
FDARegeneron PharmaceuticalsSanofi

Keep exploring

Part of

Sanofi, Regeneron, and Bayer are involved in new market developments, including FDA submissions regarding eczema and eye care treatments. All 2 developments

Within Major pharmaceutical companies including Sanofi, Regeneron, Roche, Eli Lilly, Biogen, and Gilead are maintaining alliances and competing across key therapeutic areas like ophthalmology, immunology, and oncology.

The entities involved

Coverage

Newest first; wire copies grouped